Navigation Links
Alimera Sciences Reports Second Quarter 2014 Financial Results
Date:8/7/2014

cond Quarter 2014 Financial Results Net revenue for the second quarter of 2014 was $2.2 million, compared to $2.1 million in the first quarter of 2014 and $179,000 for the second quarter of 2013.

GAAP cost of goods sold for the second quarter of 2014 was $376,000 compared to $11,000 for the second quarter of 2013. GAAP cost of goods sold for the second quarter of 2014 were impacted by a reserve of $207,000 for potential German inventory expiration later in 2014. This reserve relates to the initial inventory build of German product in late 2012 and early 2013 in advance of the expected launch in Germany, which has not progressed as initially expected. Excluding this reserve, non-GAAP adjusted cost of goods sold was $169,000. Non-GAAP adjusted gross margin was $2.0 million, or 91%, for the second quarter of 2014, compared to $168,000, or 94%, for the second quarter of 2013.

Research and development expenses for the second quarter of 2014 decreased 18% to $1.8 million, compared to $2.2 million for the second quarter of 2013. The decrease was primarily attributable to the completion of the physician utilization study in the fourth quarter of 2013 and cost associated with April 2013 resubmission of the ILUVIEN NDA, offset by additional personnel hired in the EU following the commercial launch of ILUVIEN in Germany and the United Kingdom.

General and administrative expenses in the second quarter of 2014 increased 17% to $2.8 million, compared to $2.4 million in the second quarter of 2013. The increase was primarily attributable to additional personnel hired following the commercial launch of ILUVIEN in Germany and the United Kingdom.

Sales and marketing expenses in the second quarter of 2014 decreased 37% to $3.1 million, compared to $4.9 million for the second quarter of 2013. The decrease was primarily attributable to decreases of non-recurring marketing and market access costs incurred during the second quarter of 2013 in connection with the
'/>"/>

SOURCE Alimera Sciences, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Sangamo BioSciences Announces Presentation At The 2014 Wedbush Securities Life Sciences Management Access Conference
2. Ardelyx to Present at the Wedbush 2014 Life Sciences Management Access Conference
3. Neural ID Enables Auditing and Analysis of Biosignal Data Directly from the TIBCO Spotfire® Powerful Data Visualization Platform for PerkinElmer’s Life Sciences Customers
4. Sequenom, Inc. Announces Participation At The 2014 Wedbush Securities Life Sciences Management Access Conference
5. Applied DNA Sciences to Host Conference Call Tuesday August 12, 2014
6. iBIO Institutes PROPEL Center Awards Grants for AdvaMed 2014 to Early-Stage Life Sciences Companies
7. Rancho BioSciences, in Partnership with Omicsoft, have Integrated Array Suite with tranSMART
8. Dr. Michael E. Hogan, Ph.D., Joins Applied DNA Sciences as Vice President, Life Sciences
9. Epic Sciences Appoints Greg Lucier as Chairman of the Board of Directors
10. U.S. Environmental Protection Agency (EPA) Awards Vala Sciences a Second ToxCast Contract
11. Proove Biosciences Exhibits Industry Leading Data and Research at International Spine Intervention Society’s 22nd Annual Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... September 03, 2015 , ... The latest addition to the ... and verifies labels automatically. Companies in the pharmaceutical and healthcare industry can use the ... 500 per minute. The Label Serialization Station can be fully integrated into the production ...
(Date:9/3/2015)... 3, 2015  Guardant Health®, the leader in ... the performance and clinical utility of Guardant360® on ... and poster presentations at the International Association for ... on Lung Cancer. These abstracts were submitted by ... Davis; the University of Chicago; Sarah Cannon Research ...
(Date:9/3/2015)... Sept. 3, 2015 /PRNewswire/ - bioLytical Laboratories Inc., a ... its study " Sensitivity of a rapid point of ... by its affinity for HIV gp41 IgM antibodies " ...  This study highlights INSTI,s ability to detect early HIV ... at the 8 th annual International AIDS Society ...
(Date:9/3/2015)... September 3, 2015 According to ... System (LC (HPLC, UHPLC, Flash), GC, Other Components (Autosamplers, ... Filters, Vials) - Analysis & Global Forecasts to 2020", ... to reach around 9.223 Billion by 2020 from USD ... Browse 141 tables and 36 figures spread ...
Breaking Biology Technology:Print and Verify Labels On The Production Line With New Label Serialization Stations 2Print and Verify Labels On The Production Line With New Label Serialization Stations 3Leading Cancer Centers to Present Clinical Utility Data For Guardant360 At IASLC's 16th World Conference on Lung Cancer in Denver Sept. 6-9 2Leading Cancer Centers to Present Clinical Utility Data For Guardant360 At IASLC's 16th World Conference on Lung Cancer in Denver Sept. 6-9 3Leading Cancer Centers to Present Clinical Utility Data For Guardant360 At IASLC's 16th World Conference on Lung Cancer in Denver Sept. 6-9 4bioLytical's INSTI HIV Test Detects gp41 specific IgM Antibodies 2bioLytical's INSTI HIV Test Detects gp41 specific IgM Antibodies 3Chromatography Instruments Market Worth $ 9.223 Billion by 2020 2Chromatography Instruments Market Worth $ 9.223 Billion by 2020 3Chromatography Instruments Market Worth $ 9.223 Billion by 2020 4
... Life Sciences Industry in ... Western ... (PLSG), the organization providing capital investments and,customized company formation and ... the PLSG has reached a,significant milestone with over $10 million ...
... Huifeng,Bio-Pharmaceutical Technology, Inc. (OTC Bulletin Board: HFGB), ... and pharmaceutical raw materials,for use in pharmaceutical, ... will release financial results for their first ... 2008, after the US markets close.,Huifeng,s earnings ...
... Neurobiological,Technologies, Inc. (NTI(R)) (Nasdaq: NTII ), ... from Merz Pharmaceuticals GmbH (Merz) for sales,by ... for the treatment of,moderate-to-severe Alzheimer,s disease during ... exclusive marketing agreement, NTI currently receives,quarterly royalty ...
Cached Biology Technology:The Pittsburgh Life Sciences Greenhouse Tops $10M in Company Investments 2The Pittsburgh Life Sciences Greenhouse Tops $10M in Company Investments 3
(Date:8/24/2015)... Calif. , Aug. 24, 2015  Based on its ... recognizes DERMALOG with the 2015 African Biometrics Company of the ... has achieved substantial commercial success in Africa ... , where it has implemented one of the largest ... banks as well as the Central Bank of ...
(Date:8/18/2015)... , Aug. 18, 2015  Navitas ... key contributor to the Submission Content Management ... IRISS, a non-profit forum. Dedicated to the Implementation ... a neutral platform for industry, vendors, health ... information and work towards a standard method ...
(Date:8/12/2015)... , Aug. 12, 2015  New research ... can attack Android phones to steal users, fingerprints. ... increasing availability of fingerprint scanners on mobile devices, ... concern. To secure biometrics on mobile devices, HYPR ... augment these convenient authentication systems with strong cryptographic ...
Breaking Biology News(10 mins):Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 2Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 3Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 4Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 5Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 6Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3
... of the Blackleg fungus, which causes the most damaging disease ... time by a team of French and Australian scientists. ... University of Melbourne, who led the Australian research team, said ... Blackleg disease. "The 12,500 genes that constitute the genetic ...
... Optiqua Technologies Pte Ltd is collaborating with Nanyang ... in biomolecular sciences and sensor technology. Optiqua, ... provides the international water industry with innovative products ... detection of contaminants in water. The sensor technology ...
... , Scientists today agree that there are five molecules that ... an estimated five million Americans. The potency of these molecules ... Prof. Daniel Michaelson of Tel Aviv University,s Department ... Sciences has illuminating news about one of these five molecules ...
Cached Biology News:Uncovering the genome secrets of the Blackleg fungus 2Optiqua-NTU partnership to develop next-generation sensor technology 2Good diets fight bad Alzheimer's genes 2
5-bromo-2'-deoxyuridine (BrdU) Cell Biology Cell Proliferation Bromodeoxyuridine (BrdU) and Related Products...
Human/Rat Neurogenin-2 MAb (Clone 7G4) Protein Family: Neural Crest Cell Markers, Transcription Factors...
Human Glypican 2 Biotinylated Affinity Purified PAb...
Mouse TREM-2 Affinity Purified Polyclonal Ab...
Biology Products: